Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Post by wanttoretireearlyon Sep 11, 2020 4:54pm
216 Views
Post# 31544712

PAST, PRESENT, FUTURE

PAST, PRESENT, FUTURE

Dr. George Adams

September 10, 2020

I was attracted to the Company in 2010 as the first VMS1.0 was being clinically evaluated. Dr. Mertens, who is one of the top paediatric cardiologists in the world, had just written a review on the “forgotten ventricle” and published it in Nature*.  Everyone was beginning to understand that only analyzing the left side of the heart was ignoring half of the information about how the heart was functioning. 10 years ago only MRI could give you right-heart information and as a cardiologist told me at that time, it was traumatic for the doctor, the parents and the child to suggest a child or infant have an MRI.  From then on, I was dedicated to creating the VMS to address this need.  

 

I am often asked if 10 years later, I regret this decision and I certainly do not.  Back in the early 80s I invented an artificial medium for platelet storage and licensed it to a major blood transfusion company.  It is just now becoming the standard, 35 years later!  Significant change in medical practice takes a long time. The promise of 3D ultrasound being able to routinely yield useful information for the right heart has not materialized and so the VMS approach remains the only way to get reliable accurate measurements without waiting 3 months for an MRI appointment and spending at least an hour in the machine.

 

Ventripoint really pioneered the use of artificial intelligence (AI) with its KBR approach and no-one has been able to find another way to get MRI-grade measurements from regular 2D ultrasound exams. Yes, it has taken a lot of time and money to perfect the VMS+3.0 so it is user-friendly and fits exactly into the workflow of an echocardiography service, but now we have it and are set to change the world and stop the trauma.

https://www.ventripoint.com/ceo-blog

 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse